Evaluating the modern field reimbursement and access program: key considerations
Webinar: The growing utilization of copay accumulator programs
Biosimilars: Patents, policy, and reimbursement
How Digital Innovation Drives Improved Market Access Strategies
In this digital age, how can pharmaceutical manufacturers leverage innovative tools to prove their product's value proposition and overcome market access challenges?
Managing the Growing Expansion of Copay Accumulators
Medicare Part B: Do Providers Choose Treatment Based on Payment?
What does Medicare claims data reveal about physician-administered drugs? An Xcenda survey reveals whether physicians choose treatment based on how much they're reimbursed.
Our Most-Read Insights of 2018
A collection of AmerisourceBergen's top insights from 2018, including commercialization considerations for novel therapies, emerging trends in retail and specialty pharmacy and best practices for managing inventory in the specialty practice.
Delivering Care Beyond Prescriptions: A Marketplace Opportunity for Independent Pharmacies
The high-touch, high-quality, personalized care independent pharmacies provide creates a unique value proposition in a healthcare market where more chronically ill patients need accessible care. As payers are prioritizing improved patient outcomes and a reduction in overall healthcare costs, they need to also consider new reimbursement models for these pharmacy services, a framework under which independent pharmacies are uniquely positioned to excel.
How to Navigate Cell and Gene Therapy Reimbursement: Part Two
An executive Q&A on the role of data and the future of innovative reimbursement modeling for cell and gene therapies.
How to Navigate Cell and Gene Therapy Reimbursement: Part One
An executive Q&A on challenges and opportunities related to reimbursement, coding and coverage for cell and gene therapies.
Insight Series: Value of Patient Support Programs for Specialty Medications in Canada
Rethink: Payer Strategies for Commercializing Cell and Gene Therapies
How Clinical Quality Assessment Aligns with Fee-for-Value Care Delivery Models
An expert, data-driven evaluation can help provider practices deliver the high-quality, efficient care necessary for success in new reimbursement models.
Rethinking Reimbursement and Patient Support Following Medical Innovation
How can manufacturers approach reimbursement and patient support for cell and gene therapies and other medical innovations?
Information Exchange With Payers and Providers
What information do payers and providers want from pharma?
A Look Ahead for Health System Pharmacy
Four key health system trends and the opportunities they present for pharmacy.
What Do Payers Think About Digital Health Technologies
How are payers thinking about apps, wearables and other digital health technologies?
The Route to Market Access in Canada
Understanding the unique considerations for reimbursement in the Canadian pharmaceutical market.
Taking the Lead on Prior Authorizations
Learn about the unique opportunities pharmacies have to lower drug costs, increase revenue and improve the patient experience.
Commercializing Cell and Gene Therapies
Learn what it takes to design an effective commercialization strategy and execute an integrated solution when the patient is in the supply chain.
Transitional Care Pivots Toward Improved Performance
Analytics is trending in transitional care, with impressive results for high-risk patients.
Ten Best Practices for Success in Medication Therapy Management
Completing MTM cases can have a tremendous positive impact on the patient while delivering business value to the pharmacy. Learn more.
Take a Stand Against DIR Fees
How pharmacies can take action now.
Plugging Profit Leaks
Like a slowly dripping faucet or an improperly insulated window, gaps and inefficiencies in a business allow profits to seep out over time. Even one leak—while seemingly small—can have damaging effects on a company’s financial health. Oncology practices are no different.
Six Health Systems Trends and How They'll Impact Pharmacy
Six major drivers are changing how hospitals aim to improve the quality of care while controlling costs, but they're also potential opportunities for the health system pharmacy. This infographic explores exactly how those trends impact the pharmacy.
Understanding Barriers to Adopting Precision Medicine
Precision medicine can improve patient outcomes and increase the effectiveness of therapy but physicians must still carefully navigate certain barriers.